Camber debuts generic Tarceva
Erlotinib tablets are a kinase inhibitor indicated for the treatment of patients with certain types of cancer.
Camber is introducing erlotinib tablets, which is a generic of Tarceva.
Erlotinib tablets are a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer; and first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer, in combination with gemcitabine.
[Read more: Camber - Number 1 in Generic Approvals]
Erlotinib tablets are available in 25 mg, 100 mg, and 150 mg strengths, packaged in 30-count bottles.